Question explored with the scientific record
What causes fibromyalgia
The short version: fibromyalgia is real, painful, and poorly understood. No single cause has been found—the evidence points to a mix of genetics, past infections, and trauma, all wired together by a nervous system that cannot stop signaling pain.
The evidence is clear that the central nervous system is malfunctioning. People with fibromyalgia process touch and pressure differently—their brains amplify pain signals where healthy brains filter them out [2, 5, 7]. This is not "all in your head" in the dismissive sense. It is in the actual wiring: the insula, anterior cingulate cortex, and thalamus are hyperactive on fMRI scans, and the brain’s natural pain-blocking pathways are weakened [3]. About 40 to 50 percent of patients also show damage to the small nerve fibers in their skin, which helps explain the burning and tingling sensations [3].
Genetics play a significant role. A sibling of someone with fibromyalgia has a 27 percent chance of also developing it—that is roughly 14 times the population risk [14]. Several genes have been linked to the condition, including ones that control serotonin transport, the stress response, and pain-signaling molecules like BDNF [8, 11, 12]. But genes alone do not cause it. The evidence points to triggers: past infections (especially with Campylobacter or influenza), chronic stress, and early-life trauma each appear to nudge the system toward permanent sensitization [1, 16, 18].
| Finding | What the evidence shows |
|---|---|
| Prevalence | About 2 to 4 percent of adults globally [3, 16] |
| Heritability | Sibling recurrence risk ~27%, about 14× the general population [14] |
| Small fiber nerve damage | Seen in up to 40–50% of patients on skin biopsy [3] |
| Central sensitization | Confirmed by fMRI, PET, and quantitative sensory testing [2, 3, 5] |
| Antecedent infections | Campylobacter jejuni and influenza A/B are common triggers [18] |
My call: fibromyalgia is a real biological disorder of central pain amplification, strongly influenced by genetics and set off by infections or stress. The evidence is solid on the mechanism but thin on why some people recover and others do not. Confidence: high.
Sources used 11
-
Temporomandibular disorders and painful comorbidities: clinical association and underlying mechanisms
A critical review demonstrating that temporomandibular disorders (TMD) are comorbid with headaches, cervical spine dysfunction (CSD), and fibromyalgia, underpinned by shared central pain mechanisms such as central sensitization and impaired descending pain inhibition, with a rec…
DOI: 10.1016/j.oooo.2016.12.005 -
Fibromyalgia and Overlapping Disorders: The Unifying Concept of Central Sensitivity Syndromes
This article proposes central sensitivity syndromes (CSS) as a unifying biopsychosocial framework linking fibromyalgia with overlapping functional somatic syndromes, outlining central sensitization mechanisms, cross‑syndrome associations, and the need for standardized critical s…
DOI: 10.1016/j.semarthrit.2006.12.009 -
Fibromyalgia in Clinical Practice: Diagnosis, Mechanisms, and Evidence-Based Care
This narrative review synthesizes fibromyalgia as a multidimensional pain syndrome diagnosed by 2016 ACR criteria and managed with multimodal non-pharmacologic and selected pharmacologic therapies, while highlighting mechanistic heterogeneity and the absence of robust biomarkers.
DOI: 10.67735/scms.2025.02.0128 -
Ipsilateral cortical activation in fibromyalgia patients during brushing correlates with symptom severity
This study shows that fibromyalgia patients exhibit ipsilateral beta-band ERD in central-parietal regions during brushing, with the magnitude of this ERD correlating with clinical tender-point scores, and identifies broader insula/SI/SII involvement as compared to healthy contro…
DOI: 10.1016/j.clinph.2012.06.014 -
21 Topical Seminar Summary: CENTRAL HYPERSENSITIVITY IN MUSCULOSKELETAL PAIN
A seminar-style overview of central sensitization in chronic musculoskeletal pain, its mechanisms, assessment methods (quantitative sensory testing, DNIC, pain drawings), and implications for personalized treatment, illustrated by studies on self-discrepancies and goal adjustmen…
DOI: 10.1016/s1090-3801(09)60024-0 -
Genetics of pain and management of chronic pain by extracorporeal depuration therapies
Genetic and epigenetic factors influence pain perception and chronic pain, including fibromyalgia, while extracorporeal blood purification devices are proposed as a potential but largely unproven therapeutic option.
DOI: 10.37980/im.journal.ggcl.20232248 -
Association between brain-derived neurotrophic factor gene polymorphisms and fibromyalgia in a Korean population: a multicenter study
Multicenter study in a Korean population evaluating whether brain-derived neurotrophic factor (BDNF) gene polymorphisms are associated with fibromyalgia (FM) susceptibility and symptom severity, finding specific BDNF SNPs (notably rs11030104 and rs12273539) and certain haplotype…
DOI: 10.1186/s13075-018-1726-5 -
Fibromyalgia: Genetics and epigenetics insights may provide the basis for the development of diagnostic biomarkers
A comprehensive review synthesizing genetic and epigenetic evidence in fibromyalgia, highlighting candidate genes, DNA methylation patterns, and microRNA changes, and discussing their potential as diagnostic biomarkers and therapeutic targets.
DOI: 10.1177/1744806918819944 -
The Fibromyalgia Family Study: A Genome‐Wide Linkage Scan Study
This study conducted a genome-wide linkage scan in 116 families to identify genetic loci associated with fibromyalgia, revealing a significant linkage on chromosome 17p11.2-q11.2 and suggesting a strong genetic component to the disorder.
DOI: 10.1002/art.37842 -
Fibromyalgia Syndrome: Presentation, Diagnosis, Differential Diagnosis, and Vulnerability
This paper reviews the presentation, diagnosis, and differential diagnosis of fibromyalgia syndrome and critically evaluates the evidence linking childhood victimization to FMS, concluding that biases in sampling and recall inflate apparent associations and that shared vulnerabi…
DOI: 10.1017/s1092852900026778 -
Antecedent infections in Guillain‐Barré syndrome: a single‐center, prospective study
A single-center, prospective case-control study in Southwest Shandong, China, of 150 Guillain-Barré syndrome (GBS) patients, 150 neurologic disease controls, and 150 healthy controls identified antecedent infections (notably Campylobacter jejuni, influenza A/B, and hepatitis A) …
DOI: 10.1002/acn3.50946